SYPRINE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SYPRINE, covering 2015-03-03 to 2019-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma [Phase 1]